Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

High incidence of secondary hypertension in patients referred for renal denervation--the Copenhagen experience

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Association between antecedent blood pressure, hypertension-mediated organ damage and cardiovascular outcome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mid-regional pro-atrial natriuretic peptide and blood pressure in adolescents: Effect of gender and pubertal stage

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Fibrillin-1 genotype and risk of prevalent hypertension: A study in two independent populations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Prevalence of renal artery stenosis in subjects with moderate hypertension. A population-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Arterial wave reflection decreases gradually from supine to upright

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Atrial fibrillation is a marker of increased mortality risk in non-ischemic heart failure - results from the DANISH Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Reply to: TFC ECG in arrhythmogenic cardiomyopathy: Inadequate mixture of criteria?

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Rodent models of diabetic kidney disease: human translatability and preclinical validity

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Percutaneous renal denervation is a new treatment option for patients with resistant hypertension and little is known about the eligibility of patients referred. 100 consecutive patients were referred for renal denervation from March 2011 through September 2012. Clinical data were prospectively extracted from letters and documents from referring clinics and from our physical examination. Of the 100 patients included, 68 were men and the mean age was 60 (± 12) years. Office blood pressure was 176 (± 28)/99 (± 19) mmHg and 24-h ambulatory blood pressure 156 (± 20)/88 (± 13) mmHg. The mean number of antihypertensive agents was 4.0 (± 1.6). Nearly four-fifths (82%) of the patients were categorized as having resistant hypertension based on the criteria stated by The American Heart Association's stated criteria. Nine patients declined interest in renal denervation before completing the clinical workup program. Thus, 91 patients were screened, and of those 51 were found to be candidates for renal denervation. Forty patients were not candidates, of which secondary hypertension was the most common cause (n = 10). Only 51% of patients referred for renal denervation were eligible for treatment. The prevalence of secondary hypertension was 10% of the referred population. Secondary hypertension should therefore be considered in the evaluation of candidates for renal denervation.

OriginalsprogEngelsk
TidsskriftBlood Pressure
Vol/bind23
Udgave nummer4
Sider (fra-til)233-9
Antal sider7
ISSN0803-7051
DOI
StatusUdgivet - aug. 2014

ID: 44873723